{"schema":"hottub-news/story/v1","story":"st_5dcflkco7wiyedgpduda","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","title_en":null,"outlets":49,"brief":null,"page":"https://hottub.news/stories/lillys-eloratzp-tops-zepbound-in-mid-stage-obesity-trial-5dcflkco7w","count":49,"items":[{"id":"n_ujmn53bnnazv4zaelhxq","seq":1683975,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.torontotelegraph.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:50:39Z","seen":"2026-10-04T14:50:39Z","lang":"en","source":{"id":"torontotelegraph.com","name":"torontotelegraph.com","domain":"torontotelegraph.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_qsfuobr56u6oxa46feka","seq":1682768,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.europesun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:39:18Z","seen":"2026-10-04T14:39:18Z","lang":"en","source":{"id":"europesun.com","name":"europesun.com","domain":"europesun.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_3gal4ij5ablp4xsh5qzq","seq":1682881,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.floridastatesman.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:39:18Z","seen":"2026-10-04T14:39:18Z","lang":"en","source":{"id":"floridastatesman.com","name":"floridastatesman.com","domain":"floridastatesman.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_xpnmyxqbs7bfoj22sxza","seq":1682964,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.caribbeanherald.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:39:18Z","seen":"2026-10-04T14:39:18Z","lang":"en","source":{"id":"caribbeanherald.com","name":"caribbeanherald.com","domain":"caribbeanherald.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_khvgaqm7pzl7qvqbzovq","seq":1683036,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.californiatelegraph.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:39:18Z","seen":"2026-10-04T14:39:18Z","lang":"en","source":{"id":"californiatelegraph.com","name":"californiatelegraph.com","domain":"californiatelegraph.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_6jhgfxusetiwmpsptq2q","seq":1680421,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.parisguardian.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:21:54Z","seen":"2026-10-04T14:21:54Z","lang":"en","source":{"id":"parisguardian.com","name":"parisguardian.com","domain":"parisguardian.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_l35o5uqxwftgzdhsnqsq","seq":1680636,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.atlantaleader.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:21:54Z","seen":"2026-10-04T14:21:54Z","lang":"en","source":{"id":"atlantaleader.com","name":"atlantaleader.com","domain":"atlantaleader.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_7pbaf343yksubiqqbgva","seq":1680811,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.philippinetimes.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:21:54Z","seen":"2026-10-04T14:21:54Z","lang":"en","source":{"id":"philippinetimes.com","name":"philippinetimes.com","domain":"philippinetimes.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_ovza7miw2c5watayldoa","seq":1679066,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.londonmercury.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:08:17Z","seen":"2026-10-04T14:08:17Z","lang":"en","source":{"id":"londonmercury.com","name":"londonmercury.com","domain":"londonmercury.com"},"via":"gdelt-gkg-english","topics":["health","economy","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_wdtxp5vpwwqzmtda7j7q","seq":1679118,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.austinglobe.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T14:08:17Z","seen":"2026-10-04T14:08:17Z","lang":"en","source":{"id":"austinglobe.com","name":"austinglobe.com","domain":"austinglobe.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_4ypx5zbavhchpnmndlxq","seq":1677143,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.tucsonpost.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:55:32Z","seen":"2026-10-04T13:55:32Z","lang":"en","source":{"id":"tucsonpost.com","name":"tucsonpost.com","domain":"tucsonpost.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_yhlpbij33vxfc7dy45ya","seq":1677162,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.batonrougepost.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:55:32Z","seen":"2026-10-04T13:55:32Z","lang":"en","source":{"id":"batonrougepost.com","name":"batonrougepost.com","domain":"batonrougepost.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_7qabp5szcuymvxdldqaa","seq":1677411,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.tennesseedaily.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:55:32Z","seen":"2026-10-04T13:55:32Z","lang":"en","source":{"id":"tennesseedaily.com","name":"tennesseedaily.com","domain":"tennesseedaily.com"},"via":"gdelt-gkg-english","topics":["science","economy","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_wr2eraeaazxijw4ub7aq","seq":1675696,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.indiagazette.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:37:10Z","seen":"2026-10-04T13:37:10Z","lang":"en","source":{"id":"indiagazette.com","name":"indiagazette.com","domain":"indiagazette.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_hl2vczcc6fqhtp3i2naa","seq":1676159,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.theusnews.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:37:10Z","seen":"2026-10-04T13:37:10Z","lang":"en","source":{"id":"theusnews.com","name":"theusnews.com","domain":"theusnews.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_ghp7pl2vlylfrk76nifq","seq":1673626,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.russiaherald.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:20:42Z","seen":"2026-10-04T13:20:42Z","lang":"en","source":{"id":"russiaherald.com","name":"russiaherald.com","domain":"russiaherald.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_omhhtnv2dy4lwv5zjtca","seq":1673694,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.milwaukeesun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:20:42Z","seen":"2026-10-04T13:20:42Z","lang":"en","source":{"id":"milwaukeesun.com","name":"milwaukeesun.com","domain":"milwaukeesun.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_zljxbi5do26ir65ojnsq","seq":1672008,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.oklahomacitysun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:09:39Z","seen":"2026-10-04T13:09:39Z","lang":"en","source":{"id":"oklahomacitysun.com","name":"oklahomacitysun.com","domain":"oklahomacitysun.com"},"via":"gdelt-gkg-english","topics":["health","economy","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_ibeohjw7kvmtpsnavjbq","seq":1672051,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.sierraleonetimes.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:09:39Z","seen":"2026-10-04T13:09:39Z","lang":"en","source":{"id":"sierraleonetimes.com","name":"sierraleonetimes.com","domain":"sierraleonetimes.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_qu4snmabnhc5s4zecoma","seq":1672054,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.oklahomastar.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T13:09:39Z","seen":"2026-10-04T13:09:39Z","lang":"en","source":{"id":"oklahomastar.com","name":"oklahomastar.com","domain":"oklahomastar.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_efdzocxynxwdluulatsa","seq":1669564,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.zimbabwestar.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:51:12Z","seen":"2026-10-04T12:51:12Z","lang":"en","source":{"id":"zimbabwestar.com","name":"zimbabwestar.com","domain":"zimbabwestar.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_o3mm6t6ghqqww52r4fza","seq":1669588,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.mexicostar.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:51:12Z","seen":"2026-10-04T12:51:12Z","lang":"en","source":{"id":"mexicostar.com","name":"mexicostar.com","domain":"mexicostar.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_s4fes4sihywyzdvbsl3a","seq":1670018,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.newjerseytelegraph.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:51:12Z","seen":"2026-10-04T12:51:12Z","lang":"en","source":{"id":"newjerseytelegraph.com","name":"newjerseytelegraph.com","domain":"newjerseytelegraph.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_iq52myvikazuevshwbuq","seq":1670130,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.stlouisstar.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:51:12Z","seen":"2026-10-04T12:51:12Z","lang":"en","source":{"id":"stlouisstar.com","name":"stlouisstar.com","domain":"stlouisstar.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_uthvgaon63bugjcxrepq","seq":1670143,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.israelherald.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:51:12Z","seen":"2026-10-04T12:51:12Z","lang":"en","source":{"id":"israelherald.com","name":"israelherald.com","domain":"israelherald.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_ag7zm7obnb44ybwfcvgq","seq":1668567,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.srilankasource.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:39:19Z","seen":"2026-10-04T12:39:19Z","lang":"en","source":{"id":"srilankasource.com","name":"srilankasource.com","domain":"srilankasource.com"},"via":"gdelt-gkg-english","topics":["health","economy","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_p7wtnvdbyogjg6ixvkqq","seq":1668748,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.brazilsun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:39:19Z","seen":"2026-10-04T12:39:19Z","lang":"en","source":{"id":"brazilsun.com","name":"brazilsun.com","domain":"brazilsun.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_qfksnc3wqhjg64hsrgfa","seq":1668920,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.nigeriasun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:39:19Z","seen":"2026-10-04T12:39:19Z","lang":"en","source":{"id":"nigeriasun.com","name":"nigeriasun.com","domain":"nigeriasun.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_ujzlxs7kuy5n5wc4xkua","seq":1668961,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.singaporestar.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:39:19Z","seen":"2026-10-04T12:39:19Z","lang":"en","source":{"id":"singaporestar.com","name":"singaporestar.com","domain":"singaporestar.com"},"via":"gdelt-gkg-english","topics":["health","economy","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_7prfwn4zffhg5ne3yeka","seq":1667342,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.africaleader.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:27:10Z","seen":"2026-10-04T12:27:10Z","lang":"en","source":{"id":"africaleader.com","name":"africaleader.com","domain":"africaleader.com"},"via":"gdelt-gkg-english","topics":["health","economy","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_ollknftj6b52drvauolq","seq":1667400,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.texasguardian.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:27:10Z","seen":"2026-10-04T12:27:10Z","lang":"en","source":{"id":"texasguardian.com","name":"texasguardian.com","domain":"texasguardian.com"},"via":"gdelt-gkg-english","topics":["health","economy","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_z2h36bwe4x6765fw3paa","seq":1664860,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.pittsburghstar.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:10:27Z","seen":"2026-10-04T12:10:27Z","lang":"en","source":{"id":"pittsburghstar.com","name":"pittsburghstar.com","domain":"pittsburghstar.com"},"via":"gdelt-gkg-english","topics":["science","economy","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_au2r3vblpkgssofvq66q","seq":1665021,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.chinanationalnews.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:10:27Z","seen":"2026-10-04T12:10:27Z","lang":"en","source":{"id":"chinanationalnews.com","name":"chinanationalnews.com","domain":"chinanationalnews.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_zyibaygh6lsh4vfuo7wa","seq":1665119,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.cincinnatisun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:10:27Z","seen":"2026-10-04T12:10:27Z","lang":"en","source":{"id":"cincinnatisun.com","name":"cincinnatisun.com","domain":"cincinnatisun.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_w4uk4fewslagr7f2fhwq","seq":1665244,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.bostonstar.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T12:10:27Z","seen":"2026-10-04T12:10:27Z","lang":"en","source":{"id":"bostonstar.com","name":"bostonstar.com","domain":"bostonstar.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_fox5aakajt3swmrmczda","seq":1659834,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.neworleanssun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T11:24:12Z","seen":"2026-10-04T11:24:12Z","lang":"en","source":{"id":"neworleanssun.com","name":"neworleanssun.com","domain":"neworleanssun.com"},"via":"gdelt-gkg-english","topics":["health","economy","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_dorxjsmhmj2j54i2pdyq","seq":1659984,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.hongkongherald.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T11:24:12Z","seen":"2026-10-04T11:24:12Z","lang":"en","source":{"id":"hongkongherald.com","name":"hongkongherald.com","domain":"hongkongherald.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_aby4p3z753632hw2lhva","seq":1660255,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.jamaicantimes.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T11:24:12Z","seen":"2026-10-04T11:24:12Z","lang":"en","source":{"id":"jamaicantimes.com","name":"jamaicantimes.com","domain":"jamaicantimes.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_tj2crfuaovr7qdrklcqa","seq":1660282,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.nashvilleherald.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T11:24:12Z","seen":"2026-10-04T11:24:12Z","lang":"en","source":{"id":"nashvilleherald.com","name":"nashvilleherald.com","domain":"nashvilleherald.com"},"via":"gdelt-gkg-english","topics":["science","economy","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_muqgrxoabtnmg44rjtka","seq":1657805,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.northkoreatimes.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T11:06:26Z","seen":"2026-10-04T11:06:26Z","lang":"en","source":{"id":"northkoreatimes.com","name":"northkoreatimes.com","domain":"northkoreatimes.com"},"via":"gdelt-gkg-english","topics":["science","economy","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_z3cz4s52hblmknamku2a","seq":1657924,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.vietnamtribune.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T11:06:26Z","seen":"2026-10-04T11:06:26Z","lang":"en","source":{"id":"vietnamtribune.com","name":"vietnamtribune.com","domain":"vietnamtribune.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_zjn7r6v4davdraqdzszq","seq":1656195,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.clevelandstar.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T10:54:23Z","seen":"2026-10-04T10:54:23Z","lang":"en","source":{"id":"clevelandstar.com","name":"clevelandstar.com","domain":"clevelandstar.com"},"via":"gdelt-gkg-english","topics":["health","economy","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_kd3cgipjnkljthuwptra","seq":1656357,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.hawaiitelegraph.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T10:54:23Z","seen":"2026-10-04T10:54:23Z","lang":"en","source":{"id":"hawaiitelegraph.com","name":"hawaiitelegraph.com","domain":"hawaiitelegraph.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_tq26jtjm5z5sqysvdpqa","seq":1656366,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.sydneysun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T10:54:23Z","seen":"2026-10-04T10:54:23Z","lang":"en","source":{"id":"sydneysun.com","name":"sydneysun.com","domain":"sydneysun.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_brtygpf6zwpckgeutnsa","seq":1654321,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.iranherald.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T10:37:14Z","seen":"2026-10-04T10:37:14Z","lang":"en","source":{"id":"iranherald.com","name":"iranherald.com","domain":"iranherald.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_npeizwyyyk7necdgus4q","seq":1654629,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.bangladeshsun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T10:37:14Z","seen":"2026-10-04T10:37:14Z","lang":"en","source":{"id":"bangladeshsun.com","name":"bangladeshsun.com","domain":"bangladeshsun.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_kf6picdwpbocy4aadqja","seq":1652716,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.coloradostar.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T10:20:36Z","seen":"2026-10-04T10:20:36Z","lang":"en","source":{"id":"coloradostar.com","name":"coloradostar.com","domain":"coloradostar.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_zosbd2vtjfzoiwv7u62q","seq":1652881,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.japanherald.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T10:20:36Z","seen":"2026-10-04T10:20:36Z","lang":"en","source":{"id":"japanherald.com","name":"japanherald.com","domain":"japanherald.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164},{"id":"n_5dcflkco7wiyedgpduda","seq":1652891,"kind":"article","title":"Lilly's EloraTZP tops Zepbound in mid-stage obesity trial","url":"http://www.irishsun.com/news/279343683/lilly-s-eloratzp-tops-zepbound-in-mid-stage-obesity-trial","published":"2026-10-04T10:20:36Z","seen":"2026-10-04T10:20:36Z","lang":"en","source":{"id":"irishsun.com","name":"irishsun.com","domain":"irishsun.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_5dcflkco7wiyedgpduda","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.25999999046325684,"political":0.019999999552965164}]}